BMY
2024Q4BMOBristol-Myers Squibb Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Street
Consensus EPS1.47
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move1.9%
IV front—
P/C full—
P/C front—
Features as of2025-02-05
Run-up
Close—
Ret 5d+1.1%
Ret 10d+4.6%
Ret 20d+5.3%
Ret 30d+6.1%
Actual EPS
1.67Beat
Estimated EPS1.47
Actual revenue
12.3B
Surprise %+13.6%
Beat / missBeat
Beat streak 43
Beat streak 83
Reaction
1-day stock reaction+0.1%
Implied vs actual
Implied 1.9%Actual 3.9%
Gap reaction-3.9%
Day result-3.8%
Next-day upYes
Realized / IV2.07×
Post tape
Post 5d-2.5%
Post 10d-2.8%
Post volume25.1M
Vol ×10d2.24×
Vol ×20d2.45×
Post range4.3%